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Abstract
 
The life history of isotype-switched B cells is unclear, in part, because of an inability to detect
rare antigen-specific B cells at early times during the immune response. To address this issue, a
small population of B cells carrying targeted antibody transgenes capable of class switching was
monitored in immunized mice. After contacting helper T cells, the first switched B cells appeared
in follicles rather than in the red pulp, as was expected. Later, some of the switched B cells
transiently occupied the red pulp and marginal zone, whereas others persisted in germinal
centers (GCs). Antigen-experienced IgM B cells were rarely found in GCs, indicating that
these cells switched rapidly after entering GCs or did not persist in this environment.
Key words: lymphocyte activation • marginal zone • T cells • transgenic mice • germinal centers
 
Introduction
 
IgG, IgA, and IgE antibodies participate in elimination of
microbes from the host by activating complement and pro-
moting phagocytosis. These antibodies are created when
naive IgM
 
 
 
, IgD
 
 
 
 B cells undergo H chain isotype switch
recombination, which involves a DNA deletion between
switch regions upstream of the 
 
 
 
, 
 
 
 
, or 
 
 
 
 H chain constant
exons (1). The accessibility of the recombinase to a particu-
lar switch region is correlated with germline transcription
and splicing (2–5), whereas the recombination process itself
is thought to be initiated by the activity of activation-
induced cytidine deaminase (6, 7). Signals promoting germ-
line transcription are regulated in vivo by cell interactions
and secreted cytokines (8). Thus, although some switch re-
combination can occur in response to certain polyvalent
antigens in a T cell–independent fashion, switching is
greatly facilitated by cognate interactions with antigen-spe-
cific CD4 helper T cells (9).
In situ detection of antigen-specific B cells has revealed
several aspects of CD4 T cell–dependent B cell activation
and isotype switching. Naive IgM
 
 
 
, IgD
 
 
 
 B2 cells circulate
through the B cell–rich follicles of secondary lymphoid tis-
sues (10). After exposure to antigen, antigen-binding
IgM
 
 
 
, IgD
 
 
 
 B cells migrate from random positions within
the follicles to the border between the follicles and T cell–
rich areas (11–13), where cognate interactions with anti-
gen-specific CD4 T cells can occur (14). The B cells prolif-
erate and foci of antibody-secreting plasmablasts, some of
which contain isotype-switched antibodies, appear at the
border between the T cell areas and the red pulp of the
spleen, 6–8 d after immunization (11, 15). Shortly after
the foci appear, clusters of isotype-switched B cells that
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stain with the PNA lectin appear in germinal centers (GCs;
 
*
 
reference 15) within the areas of the follicles occupied by
follicular dendritic cells (16). B cells expressing B cell re-
ceptors (BCRs) consisting of the same germline V
 
H
 
 and V
 
L
 
segments are present in the foci and GCs (17). However,
those within the GCs contain somatic mutations in their
BCRs, whereas those within the foci do not (18, 19). Be-
cause long-lived memory B cells contain somatic mutations
(20), and because somatic mutations are thought to occur
primarily in GCs (18, 21), it is thought that all memory B
cells are derived from GCs.
These results have led to the current model in which an-
tigen-specific B cells receive signals from CD4 helper T
cells at the T cell–area follicle border, proliferate there and
either migrate to the outer T cell area near the red pulp,
differentiate into plasmablasts, and undergo isotype switch-
ing; or migrate to the GCs and undergo somatic mutation
and isotype switching there. One limitation of this model is
that the aspects related to isotype switching are based on
studies in which rare antigen-specific B cells could only be
detected after clonal expansion. Thus, critical events in the
isotype switching process that occur before antigen-specific
B cells undergo extensive proliferation could have been
missed. This possibility is addressed here with a novel
adoptive transfer system in which isotype switching by ini-
tially naive antigen-specific B cells can be monitored in situ
before B cell clonal expansion.
 
Materials and Methods
 
Mice. 
 
All transgenic mice were bred in a pathogen-free fa-
cility according to National Institutes of Health guidelines. The
DO11.10 TCR transgenic B10.D2nSn/J mice (22) were ob-
tained from Dr. T. Mitchell (National Jewish Medical Center,
Denver, CO). 3-83 IgM/D transgenic B10.D2nSn/J mice (23)
and 3-83 knockin homozygous (KIH) mice (24, 25) were pro-
duced at the National Jewish Medical Center. The OT-II TCR
transgenic C57BL/6 mice (26) were provided by Dr. L. Lefran-
cois (University of Connecticut, Farmington, CT) and crossed
to C57BL/6.PL mice. The anti–hen egg lysozyme (HEL) KIH
mice were produced by crossing anti-HEL H chain knockin
mice, generated in 129 embryonic stem cells by introducing the
VDJ gene segment from the HyHEL10 antibody into the H
chain locus in place of Jh1–4 (unpublished results), with anti-
HEL L chain mice (27) until they were homozygous at the H
chain and heterozygous at the L chain loci. Approximately 80%
of the splenic B220
 
 
 
 cells from anti-HEL KIH mice expressed
HEL-binding IgM at similar levels to the splenic B cells in HEL-
Ig MD4 transgenic mice (28; unpublished data). B10.D2nSn/J,
C57BL/6, and 129 
 
 
 
 C57BL/6 F
 
1
 
 recipient mice were pur-
chased from The Jackson Laboratory and maintained in a con-
ventional facility.
 
Immunization. 
 
An OVA-mim was produced by inserting
three tandem OVA 323–339 epitopes and the 17-amino acid
 
mimotope peptide in frame into the pIII protein of M13, and
purified as described previously (29). Purified OVA-mim, con-
taining 20 
 
 
 
g pIII protein, was injected intravenously. A chemi-
cal conjugate (OVA–DEL) between OVA (Sigma-Aldrich) and
duck egg lysozyme (DEL; Worthington Biochemical Corpora-
tion) was prepared with glutaraldehyde and purified as described
previously (14). 12.5 
 
 
 
g OVA–DEL was mixed with 25 
 
 
 
g LPS
and injected intravenously.
 
Adoptive Transfer. 
 
Lymph node and spleen cell suspensions
from DO11.10 or OT-II TCR transgenic donors and 3-83 IgM/D,
3-83 KIH, or anti-HEL KIH transgenic donors were prepared for
adoptive transfer as described previously (30). In some experi-
ments, 3-83 IgM/D or 3-83 KIH cell suspensions were labeled
with 5 
 
 
 
M carboxyfluorescein diacetate succinimidyl ester
(CFSE; Molecular Probes) as described previously (31, 32).
Lymph node and/or spleen cells containing a mixture of 2.5 
 
 
 
10
 
6
 
 TCR transgenic T cells and 7.5 
 
 
 
 10
 
6
 
 BCR transgenic B
cells were injected into the tail veins of recipient mice. DO11.10
T cells and 3-83 KIH B cells were transferred into B10.D2 recip-
ients. For analysis of early times after immunization (days 2 and
4), OT-II T cells and anti-HEL KIH B cells were transferred into
C57BL/6 recipients. For analysis of later times (day 11), OT-II T
cells and anti-HEL KIH B cells were transferred into 129
C57BL/6 F
 
1
 
 recipients. Because the anti-HEL KIH mice were
on a mixed C57BL/6 and 129 background, use of the F
 
1
 
 recipi-
ents prevented rejection of the anti-HEL KIH B cells (which be-
comes prominent after day 4) due to minor histocompatibility
antigen differences.
CD4 T cells were depleted by an intraperitoneal injection of
1 mg anti-CD4 mAb (GK1.5; American Type Culture Collec-
tion) 2 d before immunization.
 
ELISA. 
 
Sera were titrated in 96-well plates (Costar) coated
with 20 
 
 
 
g/ml S23 mAb specific for 3-83 Ig (unpublished data)
and blocked with 1% BSA. Plate-bound Ig was revealed by incu-
bating the wells sequentially with biotinylated anti-IgM
 
a
 
 or anti-
IgG2a
 
a
 
 (both from BD Biosciences), horseradish peroxidase
(HRP)–labeled streptavidin (Sigma-Aldrich), and the chromagen
2,2
 
 
 
-azido-bis (3-ethylbenz-thiazoline-6-sulfonic acid) (Sigma-
Aldrich). The titer at half the maximal OD was calculated for
each sample.
 
Flow Cytometry. 
 
Explanted spleens were injected with, and
minced in, a solution containing 400 U/ml collagenase (Boeh-
ringer). After a 15-min incubation at 37
 
 
 
C, 1 ml 100 mM EDTA
was added for 5 min, followed by 8 ml 5 mM EDTA in EHAA
(Biosource International). The tissue fragments were mashed,
passed through a fine mesh, washed, and were resuspended in
culture supernatant containing 24G2 mAb (American Type Cul-
ture Collection) plus 1% mouse serum (Sigma-Aldrich) and 1%
rat serum (Sigma-Aldrich) to block Fc receptors.
The resulting cell suspensions were incubated with fluoro-
chrome-labeled antibodies (from BD Biosciences unless other-
wise indicated) to detect transferred TCR or BCR transgenic
cells. DO11.10 or OT-II T cells were detected with PE-labeled
anti-CD4 and FITC-labeled KJ1–26 (Caltag) or CyChrome-
labeled anti-CD4, PE-labeled anti-V
 
 
 
2, and FITC-labeled anti-
Thy1.1, respectively. Suspensions containing 3-83 KIH B cells
were incubated with FITC-labeled S23 or FITC-labeled anti-
IgM
 
a
 
, and antibodies specific for endogenous cells (PE-labeled
anti-Thy1.2, Gr-1, anti-IgM
 
b
 
, and F480; Caltag). The cells were
fixed with 2% formaldehyde, permeabilized with 0.5% saponin
(Sigma-Aldrich), and were incubated with biotinylated anti-IgM
 
a
 
or IgG2a
 
a
 
 followed by PerCP-labeled streptavidin. The 3-83
KIH B cells were identified as FITC
 
 
 
, PerCP
 
 
 
, and PE
 
 
 
 events.
 
*
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; CFSE, carboxyfluo-
rescein diacetate succinimidyl ester; DEL, duck egg lysozyme; GC, ger-
minal center; HEL, hen egg lysozyme; HRP, horseradish peroxidase;
KIH, knockin homozygous; OVA-mim, OVA
 
-
 
mimotope–expressing
bacteriophage; PALS, periarteriolar lymphoid sheaths.T
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3-83 KIH B cells were phenotyped by staining with allophy-
cocyanin-labeled anti-B220, FITC-labeled S23, and PE-labeled
antisyndecan; or PE-labeled anti-B220 and FITC-labeled GL-7,
FITC-labeled anti-CD38, or FITC-labeled anti–I-A
 
d
 
. The cells
were fixed, permeabilized, and stained with PerCP-labeled anti-
IgM
 
a
 
 or IgG2a
 
a
 
 as described in previous paragraphs.
The anti-HEL KIH B cells were detected with 50 
 
 
 
g/ml HEL
(Sigma-Aldrich), allophycocyanin-labeled anti-B220, FITC-labeled
GL7 or anti-CD38, and biotinylated anti-HEL (33), followed by
PE-labeled streptavidin (Caltag). The cells were fixed, permeabi-
lized, and stained with PerCP-labeled anti-IgM
 
a
 
 or -IgG2a
 
a
 
 as de-
scribed in previous paragraphs.
 
Immunofluorescence. 
 
6-
 
 
 
m cryosections were dehydrated in
acetone and blocked with 1% H
 
2
 
O
 
2
 
, culture supernatant contain-
ing 24G2 mAb plus 1% mouse and 1% rat serum, and avidin–bio-
tin-blocking reagents (Vector). When multiple antigens were de-
tected with biotinylated Abs on the same section, the staining
was done sequentially, with 1% H
 
2
 
O
 
2
 
 and avidin–biotin-block-
ing performed between each antigen. The DO11.10 T cells were
detected with digoxygenin-labeled KJ1–26, followed by HRP-
conjugated anti-digoxygenin (Boehringer) and TSA-direct
Cy3-tyramide (NEN Life Science Products) according to the
manufacturer’s directions. OT-II T cells were detected with bio-
tinylated anti-Thy1.1, followed by HRP-conjugated streptavidin
(NEN Life Science Products) and TSA-direct Cy3-tyramide.
The 3-83 and anti-HEL KIH B cells were detected with bio-
tinylated anti-IgM
 
a
 
 or -IgG2a
 
a
 
 followed by HRP-conjugated
streptavidin and TSA-direct Cy5-tyramide or TSA-indirect bio-
tinyl-tyramide (NEN Life Science Products) and Cy5-labeled
streptavidin (Zymed Laboratories). M13 bacteriophage was de-
tected with biotinylated anti-phage Ab (Sigma-Aldrich) followed
by HRP-labeled streptavidin (NEN Life Science Products),
TSA-indirect biotinyl-tyramide (NEN Life Science Products),
and Cy5-conjugated streptavidin (Zymed Laboratories). PNA
 
 
 
cells were detected with biotinylated PNA (Vector) followed by
HRP-labeled streptavidin and TSA-direct Cy3-tyramide. En-
dogenous B220
 
 
 
 B cells were detected with FITC-labeled anti-
B220 mAb. Alternatively, endogenous B220
 
 
 
 B cells were re-
vealed with PE-labeled anti-B220 and IgD
 
 
 
 cells were revealed
with FITC-labeled anti-IgD mAb. Slides were analyzed with a
confocal microscope.
 
Results
 
Adoptive Transfer Model to Follow B Cell Activation and Iso-
type Switching In Vivo. 
 
To monitor early in vivo events in
the cell biology of class switching, small populations of
CD4 T and B cells from Ag receptor transgenic mice were
transferred into histocompatible normal recipients, which
were immunized with cognate antigen. CD4 T cells spe-
cific for chicken OVA peptide 323–339–I-A
 
d
 
 complexes
were obtained from DO11.10 TCR transgenic B10.D2
mice (22), and were identified with the anti-clonotypic
mAb, KJ1–26 (34). B cells were obtained from 3-83 KIH
mice that express an IgM
 
a
 
 BCR specific for the H-2K
 
k
 
MHC class I molecule (35, 36) or a mimotope peptide
identified from a random peptide library (29). The 3-83
KIH B cells were tracked with an anti-idiotypic mAb, S23,
and mAbs specific for the IgM
 
a
 
 or IgG2a
 
a
 
 allotypic deter-
minants present in 3-83 KIH Ig H chains but not in the Ig
H chains of the B10.D2 recipient mice. A bacteriophage
containing linked epitopes (OVA-mim) that could be rec-
ognized by both the DO11.10 T cells and 3-83 B cells was
used as an immunogen. Purified OVA-mim was injected
intravenously to mimic a blood-borne antigen, such as a vi-
rus, which would be composed of multiple copies of a coat
protein containing a T and B cell epitope.
Flow cytometry revealed that the transferred B and T
cells were activated after injection of OVA-mimotope bac-
teriophage. Small populations of DO11.10 T cells and 3-83
KIH IgM B cells, which were not present in untransferred
animals (Fig. 1, a and e), were detected in the spleens of re-
cipient mice (Fig. 1, b and f) after transfer. 3-83 KIH IgG2a
B cells were not detected in unimmunized recipient mice
(Fig. 1 j). Injection of the recipient mice with OVA-mim
resulted in a striking increase in the number of DO11.10 T
cells and 3-83 KIH IgM B cells in the spleen 4 d later (Fig.
1, c and g), and was accompanied by the appearance of
3-83 KIH IgG2a B cells (Fig. 1 k). The antigen-stimulated
populations of 3-83 KIH IgM and IgG2a B cells contained
cells expressing either low or high levels of intracellular Ig
(Fig. 1, g and k). The cells expressing high levels of IgM
(Fig. 2, a–e) or IgG2a (Fig. 2, f–j) were plasmablasts or
plasma cells, as evidenced by their large size, low expression
of B220, and high expression of syndecan.
It was important to assess the T cell dependence of the
3-83 response to the OVA-mim because viruses and bacte-
ria that display repetitive antigens induce both T cell–inde-
pendent and –dependent B cell responses (9). In fact,
OVA-mimotope bacteriophage can activate 3-83 B cells in
the absence of T cells, perhaps owing to their epitope mul-
tivalency (37). As shown in Fig. 1, elimination of CD4 T
Figure 1. Detection of transgenic lymphocytes. Normal mice or recip-
ients of DO11.10 T cell and 3-83 KIH B cells mice were left untreated or
depleted of CD4 T cells. Spleen suspensions were analyzed by flow cy-
tometry 4 d after immunization with OVA-mim. (a–d) CD4 , KJ1–26 ,
and DO11.10 T cells (circled region); (e and f) surface IgMa , intracellu-
lar IgMa  3-83 KIH B cells (boxed region); or (i–l) surface idiotype  (Id)
and intracellular IgG2aa  3-83 KIH B cells (boxed) are shown in the
dot plots.T
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cells, including the transferred DO11.10 T cells (Fig. 1 d),
greatly diminished the expansion of 3-83 IgM B cells (Fig.
1 h), and completely inhibited the appearance of 3-83
IgG2a B cells (Fig. 1 l) in mice 4 d after injection with the
OVA-mimotope bacteriophage, indicating that these re-
sponses were T cell–dependent.
The T cell–independent component of the B cell re-
sponse to OVA-mim was revealed with the more sensitive
CFSE dye dilution assay. Naive 3-83 IgM/D B cells did
not divide in unimmunized mice (Fig. 3 a), whereas virtu-
ally all of the 3-83 IgM/D B cells in recipients that con-
tained DO11.10 T cells divided many times by day 4 after
OVA-mim injection, as evidenced by nearly complete loss
of CFSE (Fig. 3 b). In addition, a subset of the 3-83 IgM/D
B cells divided in CD4 T cell–depleted recipients that
were injected with OVA-mim. This proliferation was Ag-
dependent and specific because it was not observed in mice
4 d after injection of wild-type bacteriophage (unpublished
data) or LPS alone (Fig. 3 d). Thus, OVA-mim induced T
cell–dependent clonal expansion and isotype switching to
IgG2a, and like many natural antigens, also induced some
T cell–independent B cell proliferation.
 
The Kinetics of Early B Cell Activation and Isotype Switching.
 
The transferred B cells underwent rapid isotype switching.
As early as day 2 after injection of OVA-mim, the number
of 3-83 IgM B cells in the spleen increased over the starting
level, and 3-83 IgG2a B cells containing low levels of intra-
cellular Ig were detected for the first time (Fig. 4 a). The
expansion of 3-83 IgM and IgG2a B cells peaked on days 3
and 4 and declined thereafter. The 3-83 IgM
 
high
 
 plasma-
blasts, which appeared on day 2 and peaked on day 3, be-
came undetectable by day 6 (Fig. 4 b). The 3-83 IgG2a
 
high
 
plasmablasts did not begin to accumulate until day 3, and
were undetectable by day 10 (Fig. 4 b). The appearance of
these Ig
 
high
 
 plasmablasts in the spleen correlated with the
presence of mimotope-specific IgM and IgG2a in the se-
rum (Fig. 4 c). The persistence of antigen-specific IgG2a
antibodies in the serum after the disappearance of the
IgG2a plasmablasts was probably related to the long serum
half-life of IgG2a (38), or the migration of plasma cells to
other sites, such as bone marrow or gut (39).
The majority of the 3-83 IgM B cell expansion and
IgG2a switching was dependent on the DO11.10 T cells
because 5–10-fold fewer 3-83 IgM and IgG2a B cells were
generated in mice that received only 3-83 B cells (Fig. 4, a
and b, open symbols). In addition, because 3-83 IgG2a B
cells could not be detected in CD4 T cell–depleted mice
injected with OVA-mim (Fig. 1 l), the appearance of small
numbers of 3-83 IgG2a B cells in mice that received only
3-83 KIH B cells was likely due to the helper activity of
endogenous bacteriophage-specific CD4 T cells.
The cell division history of the early isotype-switched B
cells was investigated because in vitro studies have shown
that isotype switching correlates with cell division (40–42).
As expected, the majority of naive 3-83 IgM cells in unim-
Figure 3. Proliferation of 3-83 IgM B cells in CD4 T cell–depleted
mice. Recipients of DO11.10 T cell and 3-83 IgM/D CFSE-labeled B
cells were left untreated or depleted of CD4 T cells. CFSE levels in the
transferred B220 , S23  B cells in spleens were analyzed by flow cytome-
try 4 d after the indicated intravenous injection.
Figure 4. Kinetics of 3-83 B
cell clonal expansion. (a and b)
DO11.10 T cell and 3-83 KIH B
cell recipients (shaded symbols)
or 3-83 KIH B cell recipients
alone (open symbols) were im-
munized with OVA-mim. At
the indicated times after immu-
nization, 3-83 KIH IgMa (cir-
cles) and IgG2aa (triangles) B
cells in the spleen that expressed
low (a) or high (b) levels of in-
tracellular Ig were measured by
flow cytometry. The total num-
ber of each B cell population was
obtained by multiplying the fre-
quency of the 3-83 B cell popu-
lation by the total number of
lymphocytes in the spleen. Each
point represents the mean  
SEM from two to four mice. (c)
Serum was collected from im-
munized recipients of DO11.10
T cells at the indicated times and
analyzed for 3-83 Ig of the IgMa
(circles) or IgG2aa (triangles) iso-
type by ELISA. Each point rep-
resents an individual mouse. The
graph is representative of three
independent experiments.
Figure 2. Phenotype of 3-83 KIH B cells. DO11.10 T cell and 3-83
KIH B cell recipients were immunized with OVA-mim. Spleen suspen-
sions were analyzed by flow cytometry 4 d after immunization. Histo-
gram plots for the indicated markers on B cells of recipient origin (gray
histograms), non-B cells (black histograms), or Ighigh (solid line) or Iglow
(dotted line) 3-83 KIH IgMa (a–e) and IgG2aa cells (f–j) are shown.T
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munized recipients retained large amounts of CFSE (Fig.
5 a). 48 h after injection of OVA-mim, 98% of the 3-83
IgG2a B cells showed decreased levels of CFSE, indicative
of three or more cell divisions (Fig. 5 c). This profile is
consistent with the cell division time of 4–8 h reported for
B cell centroblasts (43). In contrast, many of the 3-83 IgM
B cells present at this time had undergone zero, one, or
two divisions (Fig. 5 b). Therefore, 3-83 IgG2a B cells pro-
liferated to a greater extent than the 3-83 IgM B cells,
demonstrating an in vivo correlation between isotype
switching and cell division.
 
Antigen-specific IgG2a B Cells First Appear in Follicles.
 
In situ studies were performed to identify the location of
isotype switching in the spleen using mAbs specific for the
IgM
 
a
 
 or IgG2a
 
a
 
 allotypic determinants present in 3-83
KIH Ig H chains and a sensitive in situ immunofluores-
cence detection method (44). In naive recipients, scattered
3-83 IgM B cells and DO11.10 T cells were found in the
B cell–rich follicles and periarteriolar lymphoid sheaths
(PALS) of each splenic white pulp cord, respectively (Fig.
6 a). 1 d after injection of OVA-mim, the 3-83 B and
DO11.10 T cells increased slightly in number, and interac-
tions between some of these cells were observed (Fig. 6, d
and inset p) at the border between the follicles and PALS,
as expected (14). Consistent with the flow cytometry find-
ings, 3-83 IgG2a B cells were not detected until 2 d after
immunization (Fig. 6, b, e, and h, and inset q). These first
switched cells were located in B cell follicles rather than
PALS foci, as expected based on previous work (11, 15).
The majority of the switched B cells were apparently not
in contact with DO11.10 T cells. Thus, the earliest de-
tected switched B cells, which had divided at least three
times (Fig. 5), appeared to have already migrated away
from DO11.10 T cells. Importantly, this T cell–dependent
IgG2a switching appeared to occur before detectable GC
formation in the follicles.
 
Antigen-specific B Cells Form Anatomically Distinct Pop-
ulations of Plasmablasts, Pre-GC Cells, and Marginal Zone
Cells. 
 
Immunohistochemistry identified further hetero-
geneity of B cell phenotype and location as the immune re-
sponse progressed. At the peak of clonal expansion on day
4, the 3-83 IgG2a B cells, and to a lesser extent the 3-83
IgM B cells, occupied three locations (Fig. 6, j–l). One
population, located in the outer edges of the PALS near the
red pulp, contained large amounts of Ig (as evidenced by
intense staining with anti-Ig), and, thus, was probably the
intracellular Ig
 
high
 
 population detected by flow cytometry.
These cells were likely the equivalents of the PALS foci de-
scribed in previous work (11, 15). Many of these plasma-
blasts expressed surface Ig and high levels of I-A
 
d
 
 (Fig. 2, d,
e, i, and j) and were in apparent contact with the DO11.10
T cells present in the outer edges of the PALS (Fig. 6, j and
k). A second population, which contained a lower amount
of Ig, colocalized with antigen (Fig. 6, l and inset s) in the
center of B cell follicles (Fig. 6, j, k, and inset r). Although
these areas did not stain with the GC marker PNA, they
may have been the antecedents of GC because they con-
tained cells expressing CR1/2 (unpublished data) but not
IgD (Fig. 6 v). DO11.10 T cells were observed in the pre-
GC interacting with the 3-83 B cells (Fig. 6 r). A third
population having a lower level of Ig was located in the
marginal zone (Fig. 6 v). Therefore, by day 4 of the re-
sponse, the progeny of the initial follicular B cells had mi-
grated to the red pulp, pre-GC, and marginal zones.
 
3-83 IgG2a but Not 3-83 IgM B Cells Are Detected in GCs
10 d after Antigen Injection. 
 
The presence of 3-83 KIH B
cells in pre-GC on day 4 raised the possibility that 3-83
KIH B cells participated in the later GC reaction. This
possibility was tested by immunohistochemistry and flow
cytometry. By day 10, after injection of OVA-mim, GCs
containing PNA
 
 
 
 3-83 IgG2a B cells (Fig. 6, n, o, and u)
were detected in the follicles. These B cells showed evi-
dence of many cell divisions (Fig. 7 g) when compared
with naive 3-83 IgM B cells (Fig. 7 a), and contained a
population of CD38
 
low
 
 and GL-7
 
 
 
 GC phenotype cells
(Fig. 7, h and i). 3-83 IgM B cells that had not switched
were also present at this time, but were absent from GCs
and resided in the follicles and marginal zones (Fig. 6, m
and t) along with some 3-83 IgG2a B cells (Fig. 6 n).
These B cells were CD38
 
high
 
 and GL-7  (Fig. 7, e and f),
and, thus, resembled naive B cells (Fig. 7, b and c). How-
ever, they were not naive because they had divided many
times (Fig. 7 d), and were likely to be in contact with anti-
gen, which could still be detected in the red pulp and GCs
(Fig. 6 o).
One explanation for the absence of Ag-experienced
3-83 IgM cells from GC was that surface IgM does not
produce the appropriate signals for B cell retention or sur-
vival in GCs (45–48). To test this possibility, recipients of
DO11.10 T cells and 3-83 IgM/D transgenic B cells (35),
which cannot undergo isotype switching because the 3-83
V DJH/C /C  gene cassette is not integrated in the H
chain locus, were immunized with OVA-mim. As shown
in Fig. 7 j, a population of GL-7 , 3-83 IgM transgenic B
Figure 5. Proliferation of 3-83 B cells 2 d after immunization. Recipi-
ents of DO11.10 T cells and CFSE-dyed 3-83 KIH B cells were not
treated or immunized with OVA-mim. Intracellular staining was used to
detect 3-83 KIH IgMa and IgG2aa B cells in spleen suspensions prepared
48 h after immunization. The dot plots show the CFSE dye levels on in-
dicated 3-83 KIH B cells populations. The data are representative of three
independent experiments.T
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cells was detected 10 d after immunization. The 3-83 IgM
transgenic B cells could also be found in PNA  GCs (un-
published data), demonstrating that 3-83 IgM-expressing B
cells can indeed survive in GCs. Thus, although switched B
cells normally dominate the GCs, the expression of a
switched Ig is not necessary for survival in GCs, although it
may provide a competitive advantage.
Anti-HEL B Cells Behave like 3-83 B Cells.  To assess if
our results would be of predictive value in an independent
system, transfer and immunization experiments were re-
peated using naive CD4 T cells from OT-II TCR trans-
genic mice, specific for chicken OVA 323–339–I-Ab com-
plexes, naive B cells from anti-HEL KIH mice, and
intravenous immunization with an OVA–DEL conjugate.
DEL was used instead of HEL because the affinity of the
transgenic BCR for DEL is much lower than for HEL (107
M 1 vs. 1010 M 1; reference 49), and, thus, more closely
approximates the affinity of a naive BCR for its antigen.
LPS was included as an adjuvant to ensure optimal T cell
priming (50).
Anti-HEL KIH IgM B cells were found in the follicles
and OT-II T cells in the PALS (Fig. 8, a and b) of the
spleens of recipient mice after adoptive transfer. As in the
3-83 model, interactions between OT-II T and anti-HEL
KIH B cells were observed at the T-B border on day 1
(unpublished data), and anti-HEL KIH IgG2a B cells with
low levels of intracellular Ig first appeared in the follicles of
the spleen on day 2 after intravenous injection of OVA–
DEL plus LPS (Fig. 8, c and d). 4 d after antigen injection,
the anti-HEL KIH IgM and IgG2a B cells increased and
Figure 6. In situ localization
of 3-83 B cells. Adjacent spleen
sections from DO11.10 T cell
and 3-83 KIH B cell recipient
mice before immunization (a–c),
or 1 d (d–f, and inset p), 2 d (g–i,
and inset q), 4 d (j–l, close-ups r
and s), or 10 d (m–o, insets t and
u) after immunization with
OVA-mim were stained and an-
alyzed by confocal microscopy.
B220 staining (green) identifies
the B cell regions in a–u. The
DO11.10 T cells appear red in a,
b, d, e, g, h, j, k, m, n, p–r, t,
and u. 3-83 KIH IgM cells ap-
pear blue in a, d, g, j, m, p, and t.
3-83 KIH IgG2a cells appear
blue in b, e, h, k, n, q, r, and u.
PNA appears red and bacte-
riophage blue in c, f, i, l, o, and
s. In v, 3-83 KIH IgG2a cells ap-
pear green, cells that coexpress
B220 and IgD appear purple,
and cells that express B220 alone
appear red. Arrow points to the
marginal zone in v.T
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formed the same populations of Ighigh plasmablasts in the
red pulp, Iglow pre-GC cells in the center of follicles, and
marginal zone cells (Fig. 8, e and f) as were observed for
3-83 KIH B cells. On day 11 after immunization, the anti-
HEL KIH IgM B cells were GL7  and CD38high (Fig. 8, i
and j) like naive anti-HEL KIH IgM B cells (Fig. 8, g and
h), whereas the majority of the anti-HEL KIH IgG2a B
cells in the day 11–immunized recipients were GL7  and
CD38low (Fig. 8, k and l). Therefore, as in the 3-83 model,
anti-HEL KIH B cells first underwent isotype switching in
the follicles, formed three anatomically distinct popula-
tions, and persisted at later times as GC phenotype IgG
cells and non-GC phenotype IgM cells.
Discussion
By elevating the frequency of naive antigen-specific B
and T cells, we were able to track the genesis and fate of
isotype-switched B cells early on during a primary T cell–
dependent immune response. It could be argued that ele-
vating the frequency of these cells introduces variables that
are not representative of the physiological situation. Al-
though adoptively transferred lymphocytes undergo the ac-
tivation process more quickly than their endogenous coun-
terparts, evidence suggests that the quality and sequence of
the events in this process are similar. For example, endoge-
nous (51) and adoptively transferred naive antigen-specific
CD4 T cells (30) undergo the same process of clonal ex-
pansion, contraction, and memory cell generation, al-
though these steps appear to occur more rapidly in the
transferred population. Similarly, in both the endogenous
anti-NP response described by Jacob et al. (15) and in the
adoptive transfer model reported here, plasmablasts ap-
peared before GC B cells. However, both events occurred
a day or two more quickly in the adoptive transfer situa-
tion. This could be related to the elevated frequency of
helper T cells because the tempo of the primary anti-DNP
B cell response was increased in hosts that contained previ-
ously primed cognate T cells (11). Therefore, although the
rate of B cell activation may be influenced by the frequency
of helper T cells, there is no obvious reason to believe that
the order in which events occur during this process would
be changed.
The finding that antigen-specific isotype-switched B
cells were first detected in the follicles departs from the pre-
vailing view that isotype switching occurs first in foci of
plasmablasts in the red pulp and medullary cords (15, 52),
Figure 7. Phenotype of 3-83 B cells on day 10. Recipients of
DO11.10 T cells and 3-83 KIH B cells (a–i) or 3-83 IgM/D B cells (j)
were not treated or injected with OVA-mim. In some cases (a, d, and g),
the 3-83 KIH B cells were dyed with CFSE before transfer. Intracellular
staining was used to detect IgMa and IgG2aa B cells in spleen suspensions
prepared 10 d after immunization. The shaded histograms show the levels
of CFSE, GL-7, or CD38 on the indicated 3-83 KIH or 3-83 IgM/D B
cell populations. The dashed histograms show the staining on endogenous
B220  B cells in the same sample. The data are representative of two
independent experiments.
Figure 8. Response of anti-HEL KIH B cells is similar to 3-83 KIH B
cells. (a–f) Adjacent spleen sections from recipients of OT-II T cells and
anti-HEL KIH B cells before injection (a–b), or 2 d (c and d) or 4 d (e and
f) after injection of OVA–DEL plus LPS were stained and analyzed by
confocal microscopy. B220 staining (green) identifies the B cell regions.
The OT-II T cells appear red. anti-HEL KIH IgM B cells appear blue in a,
c, and e. anti-HEL KIH IgG2a B cells appear blue in b, d, and f. (g–l) Re-
cipients of OT-II T cells and anti-HEL KIH B cells were left naive or in-
jected with OVA–DEL plus LPS. Intracellular staining was used to detect
IgMa and IgG2aa B cells in spleen suspensions prepared 11 d after immuni-
zation. The shaded histograms show the levels of GL-7 or CD38 on the
indicated anti-HEL KIH B cell populations. The dashed histograms show
the staining on endogenous B220  B cells in the same sample.T
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and later in the GCs (53, 54). Our results are consistent
with a model in which IgM B cells, after receiving signals
from helper T cells at the PALS–follicle border, migrate
into follicles where they proliferate and undergo isotype
switching. Isotype-switched B cells and unswitched IgM B
cells then migrate to the red pulp, pre-GC, and marginal
zones. Isotype-switched B cells in follicles may have been
missed in previous studies of endogenous antigen-specific B
cell populations because the frequency of these cells before
clonal expansion is extremely low.
The first switched B cells did not appear to be interacting
with antigen-specific T cells in the follicles. Because very
few switched B cells appeared in mice that were not trans-
ferred with transgenic T cells, it is reasonable to suspect
that critical signals for isotype switching were delivered
earlier when IgM B cells interacted with antigen-specific T
cells at the PALS–follicle border. Previous work has shown
that T cell–dependent switching to the IgG2a isotype is de-
fective in mice lacking the CD40 ligand (55) or the IFN- 
receptor (56). It is possible that the antigen-specific B cells
received both of these signals from the interacting T cells at
the PALS–follicle border and moved away into the follicle,
already programmed to switch. This is plausible for the
CD40 ligand because this molecule is induced on naive
CD4 T cells within hours of TCR signaling (57). It is less
clear how naive T cells could have provided IFN-  so
quickly. Naive DO11.10 and OT-II T cells, like other na-
ive CD4 T cells, are very inefficient IFN-  producers un-
less stimulated to differentiate into Th1 cells (50, 58). An-
other possibility is that antigen-specific B cells received the
CD40 ligand signal from the interaction with the antigen-
specific T cells, but switched in response to IFN-  made by
the B cells themselves (29), or from another source; e.g.,
NK cells (59).
The location of the antigen-specific Ighigh B cells in the
outer PALS and red pulp suggests that they are the coun-
terparts of the NP-specific Ab-secreting PALS foci de-
scribed by Jacob et al. (15). Consistent with previous find-
ings (60), all of the antigen-specific Ighigh B cells expressed
surface Ig and MHC class II molecules. Thus, these cells
did not lose molecules involved in antigen presentation, as
has been reported for terminally differentiated plasma cells
and myeloma cells (61, 62). Our finding, that the antigen-
specific Ighigh B cells were often juxtaposed with antigen-
specific T cells at the border between the PALS and red
pulp, is consistent with the idea that they were presenting
antigen to the T cells, and in return receiving signals to dif-
ferentiate further.
The antigen-specific IgM and IgG2a B cells present in
the marginal zone after immunization could have been de-
rived from naive follicular B2 cells or marginal zone B cells
because both populations are present in the spleens of un-
immunized BCR transgenic donor mice (63). We favor
the former possibility because 3-83 KIH B cells still accu-
mulated in the marginal zones in immunized recipients of
3-83 KIH lymph node cells, which do not contain mar-
ginal zone cells (Fig. 6 v). Activated B2 cells may traffic to
the marginal zone because antigen is retained there by mar-
ginal zone macrophages or because the B cells acquire ex-
pression of integrins that are required for retention in the
marginal zone (64).
The antigen-specific IgM, and particularly, the antigen-
specific IgG2a B cells present in the follicles on day 4 were
located in areas where antigen was concentrated, presum-
ably on follicular dendritic cells (16). The interactions be-
tween antigen-specific T cells and antigen-specific B cells
that were observed in these regions may be evidence of the
process whereby helper T cells provide sustaining signals to
B cells in GC (16).
The total number of antigen-specific B cells present in
the spleen fell dramatically by day 10 after immunization.
The loss was partly explained by the disappearance of anti-
gen-specific Ighigh plasmablasts, perhaps as a result of apop-
tosis or migration to the bone marrow (60, 65). Many of
the surviving antigen-specific IgG2a cells expressed GC
markers and were located in PNA  GCs, whereas the sur-
viving antigen-specific IgM cells lacked GC markers, and
were located outside of GCs. This absence of IgM cells
from the GCs was particularly striking because these B
cells were 10 times more abundant than antigen-specific
IgG2a B cells at this time. Because the antigen-specific
IgM cells were capable of entering early GCs, as indicated
by their presence on day 4 in the follicular dendritic cell–
rich regions, their absence from PNA  GCs on day 10
suggests an inability to persist in GC. The lack of persis-
tence of antigen-specific IgM B cells in GCs is inconsis-
tent with a previous paper that found PNA  IgM B cells
persisting throughout a primary response to sheep red
blood cells (66). However, this work followed a poly-
clonal B cell response, and, thus, it is possible that a
steady-state level of newly activated, transiently migrating
B cell clones were continuously being recruited into the
PNA  IgM  fraction.
Several explanations are possible for the failure of anti-
gen-experienced IgM B cells to persist in PNA  GCs. Sub-
sequent engagement of surface IgG2a by antigen, but not
IgM, may produce intracellular signals required for survival
or retention in GCs (45–48). This does not appear to be
the case because adoptively transferred 3-83 transgenic IgM
B cells, and transgenic B cells in other models (67–69), can
persist in GCs. Alternatively, the antigen-specific IgM cells
that entered the follicular dendritic cell–rich regions may
not have persisted because they underwent rapid isotype
switching in this location, perhaps due to the abundance of
antigen-specific T cells that were also present.
Finally, it is likely that some of the antigen-specific B
cells present in the spleen 10 d after immunization were
destined to enter the memory pool (70). The antigen-spe-
cific IgG2a B cells in the GCs are good candidates because
it is thought that memory B cells are derived from the GC
reaction. However, the antigen-specific IgM B cells that
remained in the follicles and marginal zone are also candi-
dates. The latter cells may correspond to the IgM memory
population that survives in the marginal zone of rats for
long periods of time after immunization (11, 71). Similarly,
IgM B cells with a memory phenotype have been describedT
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in humans (72–74) and mice (75). Thus, it is possible that
two populations of memory cells survive the early primary
response: (a) switched B cells that pass through the GCs
and (b) unswitched B cells that do not.
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